Small Cap Biotech
In seeking to track the performance of the S&P Biotechnology Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index (S&P TMI).
Trend Stats
1-Month Return
+7.85%
3-Month Return
+22.90%
12-Month Return
+72.37%
Volatility Score
2.5
RSI
55.1
ST Trend
Up
LT Trend
Up
Short-Term Trend
Up
The Short-Term Trend is a metric that gauges an ETF's short-term price trend.
Long-Term Trend
Up
The Long-Term Trend is a metric that gauges an ETF's long-term price trend.
Performance
Small Cap Biotech
S&P 500 Index
Components
| Symbol | Company | Market Cap | 12 mo return Performance over the past 12 months | 3 mo return Performance over the past 3 months | 1 mo return Performance over the past month | Vol Score Our gauge of the ETF's recent volatility | ST Trend A metric that gauges an ETF's short-term price trend | LT Trend A metric that gauges an ETF's long-term price trend |
|---|---|---|---|---|---|---|---|---|
| ABBV | AbbVie | $453B | +24.40% | +14.82% | +5.19% | 2.1 | Neutral | Up |
| AMGN | Amgen | $236B | +58.43% | +27.25% | +12.76% | 2.1 | Up | Up |
| GILD | Gilead Sciences | $187B | +34.66% | +17.66% | +11.64% | 2.3 | Up | Up |
| VRTX | Vertex Pharma | $138B | +37.87% | +23.63% | +14.08% | 2.7 | Up | Up |
| REGN | Regeneron Pharma | $85B | +45.10% | +31.80% | +8.94% | 2.4 | Up | Up |
| MRNA | MODERNA | $58B | +478.96% | +182.13% | +155.40% | 11.2 | Up | Up |
| NTRA | Natera | $47B | +95.32% | +47.76% | +19.26% | 3.9 | Up | Up |
| RVMD | REVOLUTION MEDIC | $45B | +418.57% | +34.90% | +8.56% | 3.8 | Up | Up |
| ALNY | Alnylam Pharma | $36B | -41.13% | -12.36% | +21.51% | 3.7 | Neutral | Down |
| BIIB | Biogen | $33B | +56.98% | +12.41% | +5.94% | 2.4 | Up | Up |
| INSM | Insmed | $28B | -12.96% | +20.37% | +27.89% | 3.5 | Up | Down |
| INCY | Incyte | $26B | +46.30% | +25.20% | +5.10% | 2.5 | Up | Up |
| ROIV | ROIVANT SCIENCES | $25B | +170.36% | +18.29% | +0.98% | 3.4 | Down | Up |
| UTHR | United Therapeut | $21B | +21.74% | -10.97% | -5.99% | 2.9 | Down | Down |
| NBIX | Neurocrine Biosc | $16B | +8.01% | -7.00% | -6.27% | 2.6 | Down | Up |
| BBIO | BRIDGEBIO PHARMA | $15B | +40.20% | +11.15% | -8.81% | 3.3 | Down | Neutral |
| EXEL | Exelixis | $15B | +55.78% | +12.42% | +5.37% | 2.6 | Up | Up |
| SMMT | SUMMIT THERAP | $14B | -32.24% | +18.63% | +27.94% | 5.6 | Up | Up |
| BMRN | Biomarin Pharm | $13B | +15.16% | +17.81% | +9.57% | 3.0 | Up | Up |
| HALO | Halozyme Therape | $13B | +47.06% | +53.90% | +32.39% | 3.2 | Up | Up |
| MDGL | Madrigal Pharmct | $13B | +24.99% | +9.79% | +6.60% | 3.4 | Neutral | Up |
| ARWR | Arrowhead Phrmct | $12B | +196.96% | +14.87% | -3.63% | 3.4 | Neutral | Up |
| KRYS | KRYSTAL BIOTECH | $11B | +138.40% | +16.39% | +10.31% | 3.0 | Neutral | Up |
| CYTK | Cytokinetics | $10B | +37.18% | +0.59% | -7.49% | 3.6 | Down | Up |
| PRAX | PRAXIS PRECIS | $9.8B | +650.93% | +32.88% | +13.46% | 5.2 | Up | Up |
| KYMR | KYMERA THERAP | $9.8B | +169.80% | +57.34% | +12.45% | 4.2 | Neutral | Up |
| IONS | Ionis Pharmaceut | $9.7B | -5.13% | -22.68% | +5.48% | 3.3 | Down | Down |
| PTGX | Protagonist Ther | $9.4B | +140.74% | +41.76% | +7.30% | 3.8 | Up | Up |
| PCVX | VAXCYTE | $9.1B | +85.22% | +25.43% | +11.83% | 3.7 | Up | Up |
| TGTX | TG Therap | $8.6B | +73.81% | +38.03% | +14.88% | 4.1 | Up | Up |
| IBRX | IMMUNITYBIO | $8.6B | +236.67% | +10.84% | +16.26% | 4.6 | Neutral | Up |
| TWST | TWIST BIOSCIENCE | $8.2B | +384.16% | +68.70% | +25.42% | 7.5 | Up | Up |
| IMVT | IMMUNOVANT | $8.1B | +129.00% | +20.14% | -0.28% | 3.9 | Down | Up |
| SYRE | Spyre Therap | $7.8B | +423.41% | +13.38% | -15.21% | 5.8 | Down | Up |
| ALKS | Alkermes | $7.7B | +53.97% | +6.27% | -7.19% | 3.1 | Down | Up |
| RYTM | RHYTHM PHARM | $7.1B | +0.61% | +17.27% | -2.87% | 4.3 | Down | Up |
| SRRK | SCHOLAR RCK HLDG | $6.7B | +76.15% | +22.06% | +15.78% | 4.0 | Up | Up |
| CGON | CG ONCOLOGY | $6.6B | +125.79% | +33.13% | +4.58% | 3.8 | Neutral | Up |
| TVTX | TRAVERE THERAPET | $6.2B | +201.66% | +41.36% | +16.53% | 3.2 | Up | Up |
| MIRM | MIRUM REG S-AI | $6.2B | +32.66% | +9.09% | -3.29% | 3.4 | Down | Up |
| 0 | 0 | 0 | 0 | Bullish | Bullish |